Effects of Dietary Education Program for the Japan Diet on Cholesterol Efflux Capacity: A Randomized Controlled Trial
- PMID: 34024872
- PMCID: PMC9174087
- DOI: 10.5551/jat.62832
Effects of Dietary Education Program for the Japan Diet on Cholesterol Efflux Capacity: A Randomized Controlled Trial
Abstract
Aim: Improving cholesterol efflux capacity (CEC) of high-density lipoprotein (HDL) has been regarded as a novel target for preventing cardiovascular disease. HDL reportedly has antioxidant properties which may contribute to its functions. We investigated changes in CEC with intake of the Japan Diet (JD) recommended by the Japan Atherosclerosis Society and the relationship of these changes to serum antioxidant concentrations.
Methods: A randomized parallel controlled clinical trial on JD intake was performed in Japanese patients with dyslipidemia. Ninety-eight participants were randomly divided into the JD (n=49) or the partial JD (PJD) (n=49) group. Nutrition education, based on each diet at baseline and at 3 months, was provided and the participants were followed up for 6 months.
Results: Mean CEC was 1.05 in total and correlated positively with HDL-cholesterol (p<0.001) at baseline. CEC did not change while oxygen radical absorbance capacity (ORAC) was decreased in both groups (p<0.001). Although serum total carotenoid increased in both groups, serum α-tocopherol decreased in the JD group as compared to the PJD group (p<0.05). CEC correlated positively with HDL ORAC at baseline (p=0.021) and with serum total carotenoid at 3 and 6 months (p=0.005, 0.035). Changes in CEC correlated positively with changes in HDL ORAC at 3 months and serum total tocopherol at 3 and 6 months (p<0.001).
Conclusion: CEC was not changed by JD education in Japanese patients with dyslipidemia who already had normal CEC at baseline. CEC was suggested to be positively associated with serum α- and γ-tocopherol and HDL ORAC.
Keywords: Carotenoid; Cholesterol efflux capacity; Diet; Oxygen radical absorbance capacity; Tocopherol.
Figures

Similar articles
-
Effects of Nutrition Education Program for the Japan Diet on Serum Phospholipid Fatty Acid Compositions in Patients with Dyslipidemia: Re-analysis of Data from a Previous Randomized Controlled Trial.J Atheroscler Thromb. 2023 Dec 1;30(12):1849-1869. doi: 10.5551/jat.64154. Epub 2023 Jun 21. J Atheroscler Thromb. 2023. PMID: 37344446 Free PMC article. Clinical Trial.
-
Effects of Nutrition Education Program for the Japan Diet on Serum LDL-Cholesterol Concentration in Patients with Dyslipidemia: A Randomized Controlled Trial.J Atheroscler Thromb. 2021 Oct 1;28(10):1035-1051. doi: 10.5551/jat.60376. Epub 2021 Jan 17. J Atheroscler Thromb. 2021. PMID: 33455975 Free PMC article. Clinical Trial.
-
Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses.J Clin Lipidol. 2016 Sep-Oct;10(5):1137-1144.e3. doi: 10.1016/j.jacl.2016.06.006. Epub 2016 Jun 25. J Clin Lipidol. 2016. PMID: 27678430 Clinical Trial.
-
High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives.Cells. 2021 Mar 5;10(3):574. doi: 10.3390/cells10030574. Cells. 2021. PMID: 33807918 Free PMC article. Review.
-
High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseases.Metabolism. 2020 Mar;104:154141. doi: 10.1016/j.metabol.2020.154141. Epub 2020 Jan 8. Metabolism. 2020. PMID: 31923386 Review.
Cited by
-
Effects of Nutrition Education Program for the Japan Diet on Serum Phospholipid Fatty Acid Compositions in Patients with Dyslipidemia: Re-analysis of Data from a Previous Randomized Controlled Trial.J Atheroscler Thromb. 2023 Dec 1;30(12):1849-1869. doi: 10.5551/jat.64154. Epub 2023 Jun 21. J Atheroscler Thromb. 2023. PMID: 37344446 Free PMC article. Clinical Trial.
-
Effect of a Community-Based Program to Accelerate Referral to Physicians for Individuals at High-Risk of Lifestyle-Related Diseases: A Cluster Randomized Trial.J Atheroscler Thromb. 2023 Oct 1;30(10):1389-1406. doi: 10.5551/jat.64100. Epub 2023 Mar 5. J Atheroscler Thromb. 2023. PMID: 36878606 Free PMC article. Clinical Trial.
References
-
- Wilson PW, Abbott RD, and Castelli WP: High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis, 1988; 8: 737-741 - PubMed
-
- Talbot CPJ, Plat J, Ritsch A, and Mensink RP: Determinants of cholesterol efflux capacity in humans. Prog Lipid Res, 2018; 69: 21-32 - PubMed
-
- van Capelleveen JC, Brewer HB, Kastelein JJ, and Hovingh GK: Novel therapies focused on the high-density lipoprotein particle. Circ Res, 2014; 114: 193-204 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials